Evidence map›Paper›PMID 31484375›Full record

ArticleMolecules (Basel, Switzerland)2019

Alcohol-Supported Cu-Mediated

Victoriya V Orlovskaya, Daniel J Modemann, Olga F Kuznetsova, Olga S Fedorova, Elizaveta A Urusova, Niklas Kolks, Bernd Neumaier, Raisa N Krasikova, Boris D Zlatopolskiy

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. A simplified, robust protocol for [Scientific reports · 2025
    Article
  2. Review
  3. Simple and Efficient Synthesis ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Review
  5. Automation of Copper-MediatedMolecules (Basel, Switzerland) · 2024
    Article
  6. Preparation ofInternational journal of molecular sciences · 2023
    Article
  7. One-Pot Radiosynthesis of [Molecules (Basel, Switzerland) · 2023
    Article
  8. Next Generation Copper Mediators for the Efficient Production ofChemistry (Weinheim an der Bergstrasse, Germany) · 2023
    Article
  9. Optimization of Direct AromaticMolecules (Basel, Switzerland) · 2022
    Article
  10. Pharmaceuticals (Basel, Switzerland) · 2021
    Article
  11. Sequential Ir/Cu-Mediated Method for theJournal of the American Chemical Society · 2021
    Article
  12. Article
  13. Nucleophilic Synthesis of 6-l-[Molecules (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Victoriya V OrlovskayaN.P.Bechtereva Institute of the Human Brain, 197376 St.-Petersburg, Russia. vikaorl@list.ru.
Daniel J ModemannInstitute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany. daniel.modemann@med.uni-goettingen.de.
Olga F KuznetsovaN.P.Bechtereva Institute of the Human Brain, 197376 St.-Petersburg, Russia. kuznetsova@ihb.spb.ru.
Olga S FedorovaN.P.Bechtereva Institute of the Human Brain, 197376 St.-Petersburg, Russia. fedorova@ihb.spb.ru.ORCID 0000-0002-9122-9622
Elizaveta A UrusovaInstitute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany. e.urusova@fz-juelich.de.
Niklas KolksInstitute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany. niklas.kolks@uk-koeln.de.
Bernd NeumaierInstitute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany. b.neumaier@fz-juelich.de.ORCID 0000-0001-5425-3116
Raisa N KrasikovaN.P.Bechtereva Institute of the Human Brain, 197376 St.-Petersburg, Russia. raisa_krasikova@inbox.ru.
Boris D ZlatopolskiyInstitute of Neuroscience and Medicine, INM-5: Nuclear Chemistry, Forschungszentrum Jülich GmbH, 52425 Jülich, Germany. boris.zlatopolskiy@uk-koeln.de.ORCID 0000-0001-5818-1260

Funding

Deutsche Forschungsgemeinschaft ZL 65/1-1Российский Фонд Фундаментальных Исследований (РФФИ) 16-54-12062/16
6 · The paper itself

Abstract

In the era of personalized precision medicine, positron emission tomography (PET) and related hybrid methods like PET/CT and PET/MRI gain recognition as indispensable tools of clinical diagnostics. A broader implementation of these imaging modalities in clinical routine is closely dependent on the increased availability of established and emerging PET-tracers, which in turn could be accessible by the development of simple, reliable, and efficient radiolabeling procedures. A further requirement is a

Indexed as

Fluorine RadioisotopesPositron Emission Tomography Computed TomographyFluorine Radioisotopes18Fcopper-mediatediodonium saltspositron emission tomographyradiolabeling

Identifiers

PMID31484375
PMCPMC6749259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.